Markets
Luke Kawa

Stocks crater as Federal Reserve’s inflation concern swells

The S&P 500 fell 3% — its second-worst day of 2024. The Nasdaq 100 slumped 3.6% and the Russell 2000 cratered 4.4%, its biggest loss this year.

The Invesco S&P 500 Equal Weight ETF closed below its November 5 level, erasing all of its postelection gains, as did small caps.

Day 13 in a row of breadth is bad, but this time even worse: the S&P 500’s advance-decline line was extremely negative. The number of falling stocks outnumbered those that rose by 464, the lowest reading this year.

The options market thought this would be the sleepiest Federal Reserve meeting of the year, and boy was it wrong. The S&P 500 and Russell 2000 were comfortably in the green ahead of the central bank’s rate decision. The Fed’s projections showed heightened concern about inflation risk given recent readings that have surprised to the upside as well as potential policies that might be pursued by the incoming Trump administration.

The median monetary policymaker thinks two interest-rate cuts would be appropriate in 2025; the market swung even more dramatically and now is pricing in only one 25-basis point reduction.

Some lowlights among individual stocks: Tesla fell 8.3%, Broadcom retreated by 6.9%, and GameStop was down 8.5%.

Jabil Circuit managed to book a strong 7.3% gain on the heels of its quarterly results and upgraded sales forecast.

Quantum Computing was one of the other rare Fed-proof stocks out there: shares were up about 40% heading into the announcement, and finished even higher than that.

More Markets

See all Markets
Western Digital Stock Rallies as Wall Street Raises Estimates

Western Digital rallies as Wall Street sees more gains ahead

Analysts responded to yesterday’s Western Digital earnings by rapidly ramping up price targets.

markets

Gene-editing stocks rally on Bloomberg report that FDA plans to fast-track approval process

Shares of biotechs working with gene-editing treatments rose after the industry’s top regulator told Bloomberg News that the Food and Drug Administration plans to publish a paper in early November outlining the agency’s new, faster approach to approving those treatments.

markets

Getty Images shares moon on licensing deal with Perplexity

Getty Images soared Friday after announcing a multiyear licensing deal with AI search company Perplexity AI. Reuters reports:

Under the agreement, Perplexity will integrate Getty’s API technology into its AI platform workflows, enabling users to access premium visuals while improving image attribution. The collaboration is part of a wider trend of digital platforms signing licensing deals with AI content providers to expand content access while respecting intellectual property rights and generating revenue.

Getty was up as much as 85% in the premarket trading session, but those gains are quickly dropping as holders rush to dump the stock, which has been a truly disastrous long-term trade.

In fact, Getty has had a pretty bizarre ride since it returned to the public markets on July 25, 2022, as part of a SPAC deal — in a previous life it had been publicly traded before being taken private in 2008. Within days of its return, Getty became a minor meme stock, spiking more than 250% before crashing a couple months later.

Since then, the stock’s trajectory has been abysmal. Prior to the announcement of the Perplexity AI deal on Friday, it was down 80% from its trading debut. No wonder people are trying to get out fast.

At last glance, those 85% gains in the premarket have been swamped by sellers, shrinking today’s gain for Getty down to 17%.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.